Literature DB >> 26573193

[Relationship of socioeconomic status and non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus].

Guoyu Jia1, Xuefen Li, Lu Wang, Qiang Li, Li Yang, Nali Li, Fusheng Di.   

Abstract

OBJECTIVE: To explore the relationship between socioeconomic status (SES) and non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus (T2DM).
METHODS: The medical records of Tianjin Third Central Hospital were retrospectively reviewed to identify patients who had been hospitalized for treatment of T2DM but without diagnosis of NAFLD between 2007 and 2012 and who had required a second hospitalization during this same period. Each patient was contacted by telephone for self-reporting of SES. Analysis was carried out with patients grouped according to SES (high vs. low) to determine association of SES with incidence of NAFLD at the second hospitalization; the relative risk (RR), attributable risk (AR) and attributable risk percent (ARP) were calculated. Furthermore, the correlation of SES with other clinical and socio-psychological variables was assessed.
RESULTS: The patients in the high and low SES groups showed no significant differences at baseline. For development of NAFLD by the time of the second hospitalization, the low SES group had an RR of 2.19, an AR of 20.74%, and an ARP of 54.39%. Correlation analysis showed that SES was positively correlated with body mass index (r=-0.582) and levels of glycated hemoglobin (r=-0.421), fasting serum insulin (r=-0.570), insulin resistance (as assessed by the HOMA method) (r=-0.487), low-density lipopmtein (r=-0.396) and C-reactive protein (r=-0.353) (all P<0.05), and negatively correlated with high-density lipopmtein (r =0.539) and with the scores for physical functioning (r =0.241), general health (r=0.234), social functioning (r =0.286), emotional health (r=0.251), and mental health (r=0.215) (all P<0.05).
CONCLUSION: SES is an influencing factor of NAFLD in patients with T2DM and is closely related to obesity, insulin resistance, lipid metabolic disorder, chronic inflammation and life quality in patients with NAFLD and T2DM.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26573193     DOI: 10.3760/cma.j.issn.1007-3418.2015.10.010

Source DB:  PubMed          Journal:  Zhonghua Gan Zang Bing Za Zhi        ISSN: 1007-3418


  5 in total

1.  Nonalcoholic Fatty Liver Disease: An Important Consideration for Primary Care Providers in Hawai'i.

Authors:  Robert J Pattison; James Phillip Esteban; Tomoki Sempokuya; Jakrin Kewcharoen; Sumodh Kalathil; Scott K Kuwada
Journal:  Hawaii J Health Soc Welf       Date:  2020-06-01

2.  Effect of Daisaikoto on Expressions of SIRT1 and NF-kappaB of Diabetic Fatty Liver Rats Induced by High-Fat Diet and Streptozotocin.

Authors:  Weibin Qian; Xinrui Cai; Xinying Zhang; Yingying Wang; Qiuhai Qian; Junichi Hasegawa
Journal:  Yonago Acta Med       Date:  2016-06-29       Impact factor: 1.641

3.  A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease.

Authors:  Tae Jun Kim; Dong Hyun Sinn; Yang Won Min; Hee Jung Son; Jae J Kim; Yoosoo Chang; Sun-Young Baek; Soo Hyun Ahn; Hyuk Lee; Seungho Ryu
Journal:  J Gastroenterol       Date:  2017-04-05       Impact factor: 7.527

4.  Prevalence and risk factors of non-alcoholic fatty liver disease in southwest Iran: a population-based case-control study.

Authors:  Elaheh Zarean; Reza Goujani; Ghorbanali Rahimian; Ali Ahamdi
Journal:  Clin Exp Hepatol       Date:  2019-09-05

5.  Relationships between Socioeconomic Status, Handgrip Strength, and Non-Alcoholic Fatty Liver Disease in Middle-Aged Adults.

Authors:  Jinkyung Cho; Inhwan Lee; Dong-Ho Park; Hyo-Bum Kwak; Kisuk Min
Journal:  Int J Environ Res Public Health       Date:  2021-02-16       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.